Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.03.2022 | News item

Contaminated sodium acetate injection USP not recalled in Canada due to shortage

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Health Canada has released a safety warning for the use of one lot of sodium acetate injection USP that the manufacturer, Fresenius Kabi Canada, has reported is contaminated with particulate matter; however, rather than being recalled, Health Canada has issued safety guidelines around the use of sodium acetate due to a shortage of the product. …
Metadaten
Titel
Contaminated sodium acetate injection USP not recalled in Canada due to shortage
Publikationsdatum
01.03.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-11975-y

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Antineoplastics

Case report

Tozinameran

Case report

Imatinib

Case report

Multiple drugs

Case report

Folinic-acid